Neuro-Oncology Reviews

Volume 25 Number 17
15 September 2023

Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 17, 15 September

Diaz S, Reyns N, Özduman K, Levivier M, Schulder M, Tuleasca C.
Microsurgical resection of gliomas of the cingulate gyrus: a systematic review and meta-analysis.
Neurosurg Rev. 2023 Sep 1;46(1):217
. doi: 10.1007/s10143-023-02127-9. PMID: 37656287. Review, Meta-analysis. ˍ

Gu X, He X, Wang H, Li J, Chen R, Liu H.
Dynamic Susceptibility Contrast-Enhanced Perfusion-Weighted Imaging in Differentiation Between Recurrence and Pseudoprogression in High-Grade Glioma: A Meta-analysis.
J Comput Assist Tomogr. 2023 Sep 1
. doi: 10.1097/RCT.0000000000001543. PMID: 37654056. Meta-analysis˰ ˍ

Pournajaf S, Afsordeh N, Pourgholami MH.
In vivo C6 glioma models: an update and a guide toward a more effective preclinical evaluation of potential anti-glioblastoma drugs.
Rev Neurosci. 2023 Sep 1
. doi: 10.1515/revneuro-2023-0067? PMID: 37651618. Review˰ ˍ

Bertero L, Mangherini L, Ricci AA, Cassoni P, Sahm F.
Molecular neuropathology: an essential and evolving toolbox for the diagnosis and clinical management of central nervous system tumors.
Virchows Arch. 2023 Sep 2
. doi: 10.1007/s00428-023-03632-4. PMID: 37658995. Review. ˍ

Li X, Liu K, Xing L, Rubinsky B.
A review of tumor treating fields (TTFields): advancements in clinical applications and mechanistic insights.
Radiol Oncol. 2023 Sep 4;57(3):279-291
. doi: 10.2478/raon-2023-0044. PMID: 37665740. Review. ˍ

Lucerón-Lucas-Torres M, Cavero-Redondo I, Martínez-Vizcaíno V, Bizzozero-Peroni B, Pascual-Morena C, Álvarez-Bueno C.
Association between wine consumption and cancer: a systematic review and meta-analysis.
Front Nutr. 2023
Sep 4;10:1197745. doi: 10.3389/fnut.2023.1197745. PMID: 37731399. Review, Meta-analysis. ˍ


Oster C, Schmidt T, Agkatsev S, Lazaridis L, Kleinschnitz C, Sure U, Scheffler B, Kebir S, Glas M.
Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005-2022.
Neurooncol Adv. 2023 Sep 4;5(1):vdad105. doi: 10.1093/noajnl/vdad105. PMID: 37811538. Review.

Zhang L, Jiang Y, Zhang G, Wei S.
The diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma.
Front Immunol. 2023 Sep
4;14:1238233. doi: 10.3389/fimmu.2023.1238233. PMID: 37731483. Review. ˍ

Alizadeh M, Broomand Lomer N, Azami M, Khalafi M, Shobeiri P, Arab Bafrani M, Sotoudeh H.
Radiomics: The New Promise for Differentiating Progression, Recurrence, Pseudoprogression, and Radionecrosis in Glioma and Glioblastoma Multiforme.
Cancers (Basel). 2023 Sep 5;15(18):4429
. doi: 10.3390/cancers15184429. PMID: 37760399. Review. ˍ

Esteban-Rodríguez I, López-Muñoz S, Blasco-Santana L, Mejías-Bielsa J, Gordillo CH, Jiménez-Heffernan JA.
Cytological features of diffuse and circumscribed gliomas.
Cytopathology. 2023 Sep 5
. doi: 10.1111/cyt.13300. PMID: 37668299. Review˰ ˍ

Li F, Wu H, Du X, Sun Y, Rausseo BN, Talukder A, Katailiha A, Elzohary L, Wang Y, Wang Z, Lizée G.
Epidermal Growth Factor Receptor-Targeted Neoantigen Peptide Vaccination for the Treatment of Non-Small Cell Lung Cancer and Glioblastoma.
Vaccines (Basel). 2023 Sep 5;11(9):1460
. doi: 10.3390/vaccines11091460. PMID: 37766136. Review. ˍ

Pasquini L, Peck KK, Jenabi M, Holodny A.
Functional MRI in Neuro-Oncology: State of the Art and Future Directions.
Radiology. 2023 Sep 5;308(3):e222028
. doi: 10.1148/radiol.222028. PMID: 37668519. Review. ˍ

Bocanegra-Becerra JE, Batista S, Costa Vieitas F, Takahashi R, Oliveira LB, Castillo-Huerta NM, Ludeña-Esquivel A, Bertani R.
Awake surgery for glioma resection during pregnancy: a systematic review.
Neurosurg Rev. 2023 Sep 6;46(1):228
. doi: 10.1007/s10143-023-02135-9. PMID: 37674009. Review˰ ˍ

Gimple RC, Prager BC, Xie Q.
Editorial: Epigenetic and metabolic regulation of primary and metastatic brain cancers.
Front Oncol. 2023 Sep 7;13:1271851. doi: 10.3389/fonc.2023.1271851. PMID: 37746272. Editorial. ˍ

Joyce T, Jagasia S, Tasci E, Camphausen K, Krauze AV.
An Overview of CD133 as a Functional Unit of Prognosis and Treatment Resistance in Glioblastoma.
Curr Oncol. 2023 Sep 7;30(9):8278-8293
. doi: 10.3390/curroncol30090601. PMID: 37754516. Review. ˍ

Sulman EP, Eisenstat DD.
Editorial: 365 days of progress in neuro-oncology and neurosurgical oncology.
Front Oncol. 2023 Sep 7;13:1279957
. doi: 10.3389/fonc.2023.1279957. PMID: 37746263. Editorial. ˍ

Yasinjan F, Xing Y, Geng H, Guo R, Yang L, Liu Z, Wang H.
Immunotherapy: a promising approach for glioma treatment.
Front Immunol. 2023 Sep 7;14:1255611∟. doi: 10.3389/fimmu.2023.1255611
. PMID: 37744349. Review. ˍ

Ahmed MH, Canney M, Carpentier A, Thanou M, Idbaih A.
Unveiling the enigma of the blood-brain barrier in glioblastoma: current advances from preclinical and clinical studies.
Curr Opin Oncol. 2023 Sep 8
. doi: 10.1097/CCO.0000000000000990. PMID: 37681417. Review. ˍ

Bartusik-Aebisher D, Woźnicki P, Dynarowicz K, Aebisher D.
Photosensitizers for Photodynamic Therapy of Brain Cancers-A Review.
Brain Sci. 2023 Sep 8;13(9):1299
. doi: 10.3390/brainsci13091299. PMID: 37759900. Review. ˍ

Dalmage M, LoPresti MA, Sarkar P, Ranganathan S, Abdelmageed S, Pagadala M, Shlobin NA, Lam S, DeCuypere M.
Survival and neurological outcomes after stereotactic biopsy of diffuse intrinsic pontine glioma: a systematic review.
Neurosurg Pediatr. 2023 Sep 8:1-8. doi: 10.3171/2023.7.PEDS22462. PMID: 37724839. Review˰ ˍ

Formentin C, Joaquim AF, Ghizoni E.
Posterior fossa tumors in children: current insights.
Eur J Pediatr. 2023 Sep 8
. doi: 10.1007/s00431-023-05189-5. PMID: 37679511. Review˰ ˍ

McDonald B, Barth K, Schmidt MHH.
The origin of brain malignancies at the blood-brain barrier.
Cell Mol Life Sci. 2023 Sep 9;80(10):282
. doi: 10.1007/s00018-023-04934-1. PMID: 37688612. Review. ˍ

Liang T, Song Y, Gu L, Wang Y, Ma W.
Insight into the Progress in CAR-T Cell Therapy and Combination with Other Therapies for Glioblastoma.
Int J Gen Med.
2023 Sep 11;16:4121-4141. doi: 10.2147/IJGM.S418837. PMID: 37720174. Review. ˍ

Otero JJ.
The Cognitive Framework Behind Modern Neuropathology.
Arch Pathol Lab Med. 2023 Sep 11
. doi: 10.5858/arpa.2023-0209-RA. PMID: 37694567. Perspective. ˍ

Avila EK, Tobochnik S, Inati SK, Koekkoek JAF, McKhann GM, Riviello JJ, Rudà R, Schiff D, Tatum WO, Templer JW, Weller M, Wen PY.
Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management.
Neuro Oncol. 2023 Sep 12:noad154
. doi: 10.1093/neuonc/noad154. PMID: 37699031. Review. ˍ


Chen C, Du X, Yang L, Liu H, Li Z, Gou Z, Qi J.
Research on application of radiomics in glioma: a bibliometric and visual analysis.
Front Oncol. 2023 Sep 12;13:1083080
. doi: 10.3389/fonc.2023.1083080. PMID: 37771434. Bibliometric analysis. ˍ

Chen Y, Qu W, Tu J, Qi H.
Implications of Advances in Studies of O6-Methylguanine-DNA- Methyltransferase for Tumor Prognosis and Treatment.
Front Biosci (Landmark Ed). 2023 Sep 12;28(9):197
. doi: 10.31083/j.fbl2809197. PMID: 37796680. Review. ˍ

Tang OY, Binder ZA, O'Rourke DM, Bagley SJ.
Optimizing CAR-T Therapy for Glioblastoma.
Mol Diagn Ther. 2023 Sep 12
. doi: 10.1007/s40291-023-00671-0. PMID: 37700186. Review˰ ˍ

Wang Q, Xin X, Dai Q, Sun M, Chen J, Mostafavi E, Shen Y, Li X.
Medulloblastoma targeted therapy: From signaling pathways heterogeneity and current treatment dilemma to the recent advances in development of therapeutic strategies.
Pharmacol Ther. 2023 Sep 12;250:108527
. doi: 10.1016/j.pharmthera.2023.108527. PMID: 37703952. Review˰ ˍ

Ge Z, Zhang Q, Lin W, Jiang X, Zhang Y.
The role of angiogenic growth factors in the immune microenvironment of glioma.
Front Oncol. 2023 Sep 13;13:1254694
. doi: 10.3389/fonc.2023.1254694. PMID: 37790751. Review. ˍ

Liu KX, Haas-Kogan DA, Elhalawani H.
Radiotherapy for Primary Pediatric Central Nervous System Malignancies: Current Treatment Paradigms and Future Directions.
Pediatr Neurosurg. 2023 Sep 13
. doi: 10.1159/000533777? PMID: 37703864. Review. ˍ

Ramakrishnan D, von Reppert M, Krycia M, Sala M, Mueller S, Aneja S, Nabavizadeh A, Galldiks N, Lohmann P, Raji C, Ikuta I, Memon F, Weinberg BD, Aboian MS.
Evolution and implementation of radiographic response criteria in neuro-oncology.
Neurooncol Adv. 2023 Sep 13;5(1):vdad118. doi: 10.1093/noajnl/vdad118. PMID: 37860269. Review.

Ribeiro M, Yordanova YN, Noblet V, Herbet G, Ricard D.
White matter tracts and executive functions: a review of causal and correlation evidence.
Brain. 2023 Sep 13:awad308
. doi: 10.1093/brain/awad308. PMID: 37703295. Review˰ ˍ

Sailunaz K, Alhajj S, Özyer T, Rokne J, Alhajj R.
A survey on brain tumor image analysis.
Med Biol Eng Comput. 2023 Sep 13
. doi: 10.1007/s11517-023-02873-4. PMID: 37700082. Review˰ ˍ

Tang J, Dong Z, Sheng J, Yang P, Zhao W, Xue J, Li Q, Lv L, Lv X.
Advances in the relationship between temporal muscle thickness and prognosis of patients with glioblastoma: a narrative review.
Front Oncol. 2023 Sep 13;13:1251662
. doi: 10.3389/fonc.2023.1251662. PMID: 37771443. Review. ˍ

Weiser A, Sanchez Bergman A, Machaalani C, Bennett J, Roth P, Reimann RR, Nazarian J, Guerreiro Stucklin AS.
Bridging the age gap: a review of molecularly informed treatments for glioma in adolescents and young adults.
Front Oncol. 2023 Sep 13;13:1254645
. doi: 10.3389/fonc.2023.1254645. PMID: 37781183. Review. ˍ

Chen M, Bie L, Ying J.
Cancer cell-intrinsic PD-1: Its role in malignant progression and immunotherapy.
Biomed Pharmacother. 2023 Sep 14;167:115514
. doi: 10.1016/j.biopha.2023.115514. PMID: 37716115. Review. ˍ

Li WS, Zhang QQ, Li Q, Liu SY, Yuan GQ, Pan YW.
Innate immune response restarts adaptive immune response in tumors.
Front Immunol. 2023 Sep 14;14:1260705
. doi: 10.3389/fimmu.2023.1260705. PMID: 37781382. Review. ˍ

Morales CS, Grodzinski P.
Current landscape of treating different cancers using nanomedicines: Trends and perspectives.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Sep 14:e1927
. doi: 10.1002/wnan.1927. PMID: 37706362. Review˰ ˍ

Zheng Y, Ma X, Feng S, Zhu H, Chen X, Yu X, Shu K, Zhang S.
Dendritic cell vaccine of gliomas: challenges from bench to bed.
Front Immunol. 2023 Sep
14;14:1259562. doi: 10.3389/fimmu.2023.1259562. PMID: 37781367. Review. ˍ

Zhou S, Sun H, Choi SI, Yin J.
Present Status and Advances in Chimeric Antigen Receptor T Cell Therapy for Glioblastoma.
Front Biosci (Landmark Ed). 2023 Sep 15;28(9):206
. doi: 10.31083/j.fbl2809206. PMID: 37796692. Review. ˍ